Special COVID-19 Christopher Magazine

Antonio Giordano, MD, PhD. explains what COVID is and how to contain the infection, pointing also to what will require attention next. Please see this special release at http://online.fliphtml5.com/qlnw/zgau/#p=1  

Incidence of breast cancer in ethnic minority groups in North America and in Western Europe

Despite considerable advantages in research for treatments and therapies for breast cancer, there is a noticeable lack of resources which emphasizes racial disparities and socioeconomic status. Breast cancer (BC) is one of the most prevalent cancer types among women, and among the top cancer deaths. Research to address this worldwide issue has been conducted to …

The evidence on the use of a ‘Cancer Vaccine’ is encouraging

The day when the two RNA-based anti-covid-19 vaccines, Pfizer and Moderna, were authorized for use was an important moment for us all. Messenger RNA (mRNA) carries information for the construction of proteins in cells. A major obstacle to overcome in designing an RNA-based vaccine is the limitation is mRNA's extreme instability. mRNA tends to degrade …

Sbarro Health Research Organization (SHRO) Arrives in Campania

Professor Antonio Giordano, MD, Phd, President - SHRO and Giancarlo Arra, Vice President - SHRO “If I have seen further it is by standing on the shoulders of Giants” – Sir Isaac Newton (in a letter to Robert Hooke, 1675) Sbarro Health Research Organization (SHRO), based in Temple University Campus, Philadelphia, USA, has arrived in …

Temple Law Signs First Partnership in Southern Italy

News update from Temple University, Beasley School of Law Università degli Studi di Napoli - Parthenope (source Wikipedia, author: Il mattino) May 25, 2022, was marked as a significant date for the Temple University and the University of Naples Parthenope as both the universities signed an agreement between their law schools to facilitate joint international …

Sbarro Health Research Organization (SHRO) ‘Charity Gala Event’ in Naples, Italy – 16th June 2022

Sbarro Health Research Organization (SHRO), a world center of excellence for cancer research based in Philadelphia, has organized a ‘Charity Gala Dinner’ in Vico Equense, a beautiful coastal town of Naples in Southern Italy, at Le Axidie Resort, on the 16th of June 2022 8 p.m. onwards. Professor Antonio Giordano, MD, Ph.D., Founder & Director …

The 2000-year-old genome and the eruption of Mount Vesuvius ~ Antonio Giordano, MD, PhD

Pompeii, reproduction of unearthed human figure (not actual) [source: canva] A unique study, published by “Scientific Report” revealed the DNA content of one of the inhabitants of Pompeii from around 2000 years ago, who likely lived at the time of the eruption of Mount Vesuvius in 79 AD. Up to now, only fragments of mitochondrial …

The use of HPV test to prevent cervical cancer ~ Dr. Antonio Giordano (Sbarro Institute / SHRO)

Women infected with the papillomavirus have a higher risk of cervical cancer. The HPV test has contributed to the progress of HPV infection diagnosis because it has allowed demonstrating how the virus and its variants, known as serotypes, spreads and has also highlighted the infections caused by strains with high oncogenic risk. HPV is a …

Everything you need to know about Clinical Trials ~ by Prof Antonio Giordano

A clinical study or a clinical trial is generally medical research, which requires the participation of volunteers, either healthy or sick, to analyze, identify and develop new therapeutic interventions aimed at the prevention, diagnosis, and treatment of diseases. Such clinical trials help in determining which approach works better to reach the endpoint of the study …

Pregnancy and Breast Cancer ~ Antonio Giordano, M.D., Ph.D.

Pregnancy after getting diagnosed with breast cancer is possible, but one must be aware of treatments that could undermine fertility. Becoming a mother after a cancer diagnosis, especially breast cancer, is a major concern for young women as in fact treatments like chemotherapy may impair fertility or reproductive capacity. Even though current guidelines do not …

Targeting Cervical Cancer Stem Cells to Improve Outcomes

 The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments. Therapeutic targeting of CCSCs has the potential to reduce resistance to conventional therapies but also limit the occurrence of distant metastasis and relapse. Precision medicine …